Pulse Biosciences (PLSE) Accounts Payables (2015 - 2026)
Pulse Biosciences (PLSE) posted quarterly Accounts Payables of $2.8 million for Q4 2025, up 65.99% year-over-year from $1.7 million in Q4 2024, and down 6.75% quarter-over-quarter from $3.0 million in Q3 2025.
Pulse Biosciences (PLSE) Accounts Payables (2015 - 2026) Analysis & Trends
Pulse Biosciences' Accounts Payables history runs 11 years deep, the most recent figure standing at $2.8 million for Q4 2025.
- In Q4 2025, Accounts Payables rose 65.99% year-over-year to $2.8 million; the TTM figure through Dec 2025 stood at $2.8 million (up 65.99% YoY), while the FY2025 annual figure was $2.8 million, up 65.99% from the prior year.
- Accounts Payables for Q4 2025 stood at $2.8 million, down from $3.0 million in the prior quarter.
- The five-year high for Accounts Payables was $3.5 million in Q1 2022, with the low at $1.4 million in Q3 2023.
- The 5-year median for Accounts Payables is $2.0 million (2022), against an average of $2.2 million.
- The sharpest annual moves came in 2021 and 2023: Accounts Payables jumped 89.59% in 2021, then slumped 38.04% in 2023.
- Pulse Biosciences' Accounts Payables stood at $1.8 million in 2021, then fell by 14.32% to $1.6 million in 2022, then increased by 16.72% to $1.8 million in 2023, then retreated by 8.88% to $1.7 million in 2024, then soared by 65.99% to $2.8 million in 2025.
- Business Quant data shows PLSE's Accounts Payables at $2.8 million in Q4 2025, $3.0 million in Q3 2025, and $2.7 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 277.20 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 6.11 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 968.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 308.92 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 1.04 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 252.70 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 701.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 233.30 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 1.03 Bn |
| 10 | Pulse Biosciences | 3.50 Bn | 3.50 Bn | 161,000.00 | 2.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.83 Mn |
| Dec 31, 2025 | 2.78 Mn |
| Sep 30, 2025 | 2.98 Mn |
| Jun 30, 2025 | 2.74 Mn |
| Mar 31, 2025 | 2.37 Mn |
| Dec 31, 2024 | 1.67 Mn |
| Sep 30, 2024 | 1.73 Mn |
| Jun 30, 2024 | 1.64 Mn |
| Mar 31, 2024 | 1.71 Mn |
| Dec 31, 2023 | 1.84 Mn |
| Sep 30, 2023 | 1.41 Mn |
| Jun 30, 2023 | 1.79 Mn |
| Mar 31, 2023 | 2.16 Mn |
| Dec 31, 2022 | 1.57 Mn |
| Sep 30, 2022 | 2.02 Mn |
| Jun 30, 2022 | 1.95 Mn |
| Mar 31, 2022 | 3.49 Mn |
| Dec 31, 2021 | 1.84 Mn |
| Sep 30, 2021 | 2.71 Mn |
| Jun 30, 2021 | 2.82 Mn |